Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1984-10-10
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0004-4849
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
232-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6590054-Administration, Topical,
pubmed-meshheading:6590054-Adult,
pubmed-meshheading:6590054-Atrophy,
pubmed-meshheading:6590054-Female,
pubmed-meshheading:6590054-Fluocinolone Acetonide,
pubmed-meshheading:6590054-Fluocinonide,
pubmed-meshheading:6590054-Humans,
pubmed-meshheading:6590054-Skin
|
pubmed:year |
1984
|
pubmed:articleTitle |
Cutaneous atrophy secondary to topical steroids.
|
pubmed:publicationType |
Journal Article,
Case Reports
|